Exercise training for cardiovascular prevention in patients with cancer.
Patients with cancer usually report limitations of their functional capacity, which may range from subclinical impairment of cardiopulmonary exercise reserve to poor quality of life with physical, cognitive, or psychosocial consequences. Exercise training is a potent multi-targeted approach to control pre-existing and new risk factors. Preliminary evidence shows that it is associated with a lower risk of cancer therapy-related cardiotoxicity and increased self-reported well-being in patients with cancer. Current evidence demonstrates that supervised exercise therapy, including high-intensity interval training, is safe and well-tolerated and reduces risk in subjects with cancer in the pre-, active-, and post-treatment settings. The present consensus document will discuss the role of exercise training in cardio-oncology, focusing on patients with cardiovascular diseases induced by cancer treatment and on those who received cardiotoxic therapies.
Authors
Piepoli Piepoli, Cohen-Solal Cohen-Solal, Ameri Ameri, Totzeck Totzeck, Anker Anker, Fervers Fervers, Lehmann Lehmann, de Keulenaer de Keulenaer, McLaughlin McLaughlin, Wilhelm Wilhelm, D'Ascenzi D'Ascenzi, Agostoni Agostoni, Halle Halle, Scott Scott, Jones Jones, Van Craenenbroeck Van Craenenbroeck, Von Haehling Von Haehling, Keramida Keramida, Adamopoulos Adamopoulos, Bayes-Genis Bayes-Genis, Sule Sule, Mouine Mouine, Niederseer Niederseer, Orso Orso, Halasz Halasz, Paolillo Paolillo, Vergaro Vergaro, Mbakwem Mbakwem, Iakobishvili Iakobishvili, Koop Koop, Sverdlov Sverdlov, Skouri Skouri, Asteggiano Asteggiano, Suter Suter, Lopez-Fernandez Lopez-Fernandez, Lyon Lyon, Farmakis Farmakis, Moura Moura, Chioncel Chioncel, Seferovic Seferovic, Coats Coats, Metra Metra, Rosano Rosano, Tocchetti Tocchetti, Volterrani Volterrani
View on Pubmed